pharmaceutical industry

By Michael Ricciardelli
In Health Law
May 8th, 2013
0 Comments
By Michael Ricciardelli
In Compliance
Jan 16th, 2013
0 Comments
The Seton Hall Law Center for Health & Pharmaceutical Law & Policy, American Health Lawyers Association (AHLA) and the Food and Drug Law Institute (FDLI) have released the first edition of the Pharmaceutical and Medical Device Compliance Manual. The Manual is a guide to deciphering the intricate web of federal and state laws and the […]...
By Michael Ricciardelli
In Health Law
Dec 11th, 2012
1 Comment
Research Fellow & Lecturer in Law Kate Greenwood published a Featured Op-ed in Pharmalot on the U.S. Supreme Court and the prospect of liability for personal injury from defects in generic drugs. In “Betting on Liability for Generic Defects,” Greenwood writes: As reported on Pharmalot, the US Supreme Court has agreed to review the First […]...
By Kate Greenwood
In Health Law
Dec 4th, 2012
2 Comments
Earlier this week, the Second Circuit Court of Appeals at last issued its decision in United States v. Caronia and it is momentous (and predicted to be heading to the Supreme Court).  A two-judge majority of the Circuit Court held that Alfred Caronia, a pharmaceutical sales representative, “was convicted for his speech – for promoting […]...
By Kate Greenwood
In Drugs & Devices
Oct 12th, 2012
1 Comment
Recently, the Food and Drug Administration announced that the manufacturer Impax Laboratories has asked the agency to withdraw its approval of a generic version of the antidepressant Wellbutrin XL 300 mg that is manufactured by Impax and marketed by Teva Pharmaceuticals.  A bioequivalence study sponsored by the FDA compared the Impax/Teva 300 mg generic to […]...